Biophytis SA (BPTSY)
8.27
+0.07
(+0.85%)
USD |
OTCM |
May 16, 16:00
Biophytis SG&A Expense (Quarterly)
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2019 | 4.020M |
| March 31, 2019 | 1.376M |
| Date | Value |
|---|---|
| June 30, 2018 | 0.8084M |
| March 31, 2018 | 1.063M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
4.020M
Minimum
Jun 2019
4.020M
Maximum
Jun 2019
4.020M
Average
4.020M
Median
Jun 2019
SG&A Expense (Quarterly) Benchmarks
| Edap TMS SA | 10.60M |
| DBV Technologies SA | 6.428M |
| Cellectis SA | 4.671M |
| Genfit SA | -- |
| Adaptimmune Therapeutics PLC | 16.88M |